||
CAR-T细胞联合治疗
https://mp.weixin.qq.com/s/Gt35e9YlY4n91LvuzYeeiQ
强强联手治疗多种癌症!6项策略让CAR-T更高效
https://mp.weixin.qq.com/s/mHYY2emuYBLShclT5VXoTg
http://www.pubmedplus.cn/P/SearchQuickResult?wd=b65fb68b-42ef-425a-b49d-317259532d47
01. | Humans | 615 篇 | 62.121% |
02. | Immunotherapy, Adoptive | 435 篇 | 43.939% |
03. | Receptors, Chimeric Antigen | 399 篇 | 40.303% |
04. | T-Lymphocytes | 299 篇 | 30.202% |
05. | Animals | 197 篇 | 19.899% |
06. | Neoplasms | 142 篇 | 14.343% |
07. | Receptors, Antigen, T-Cell | 112 篇 | 11.313% |
08. | Mice | 108 篇 | 10.909% |
09. | Female | 104 篇 | 10.505% |
10. | Tumor Microenvironment | 87 篇 | 8.788% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-8-16 00:21
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社